On the same note, the synergistic action of concurrent PDT and chemotherapy on colorectal cancer models underscores the importance of tumor volume reduction of more than 70%, owing to the complementary action of ROS and cytostatic on the HIF-1a signaling pathway [60,121]. This evidence concerns the gene HIF1A and colorectal cancer.